Articles

In this article, Dr. Robert Lee, president, Lubrizol Life Science Health (LLS Health) – CDMO Division, explores why every drug development project is unique when it comes to enhancing bioavailability and discusses how companies can overcome bioavailability challenges and...

The COVID-19 pandemic has revolutionized the health care system in India by bringing in multiple digital health technologies as the new normal. As a result, our healthcare systems are charting roadmaps to leverage digital tools to design, set up,...

Patient safety and ensuring compliance with regulations – including FDA Current Good Manufacturing Practice (CGMP) and 21 CFR part 11 – are the top priorities in the pharmaceutical industry. The industry is also facing a range of other issues,...

Many players in the pharma industry are making investments in digital solutions in order to enhance their calibration processes. But how can you make sure these investments pay off and do not negatively affect compliance or patient safety? An...

Recent trends in the research-based pharmaceuticals industry, including personalized medicine, flexible production facilities, and digitalization are impacting established processes and requiring new ways of thinking. For example, personalized medicine –treatment targeted to the individual based on a specific patient diagnosis...

Today, within the pandemic situation, mRNA or gene therapy is no longer unknown to us. Whether you are a gardener, computer engineer, or dentist, we have all received an accelerated course on how biologics are manufactured. This real-life situation...

In the IDC Info Brief: "Good Manufacturing Practices for Asia/Pacific Pharmaceutical Companies: Accelerating Transformation with Manufacturing 4.0” published in June 2021 and sponsored by Cognizant and Zenith, IDC analysts found organizations in Asia are working on their Industry 4.0...